Brugada Syndrome
38
6
6
20
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.3%
2 terminated out of 38 trials
90.9%
+4.4% vs benchmark
8%
3 trials in Phase 3/4
5%
1 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 20 completed trials
Clinical Trials (38)
Healthy-related Quality of Life and Physical Activity of Children With Cardiac Malformations
Epicardial Radiofrequency Catheter Ablation in Patients With Brugada Syndrome
Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders
National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Brugada Syndrome Substrate Characterization and Ablation
Impact on Risk Stratification of Overlap Syndrome Phenotype in Patients With E1784K Mutation in SCN5A
Clinical Cohort Study - TRUST
DNA Methylation in Brugada Syndrome and Risk of Sudden Cardiac Death
VF Mapping in Brugada and Early Repolarization Syndromes
Ablation in Brugada Syndrome for the Prevention of VF
Brugada Ablation of VF Substrate Ongoing MultiCenter Registry
The Conus Brugada Syndrome Study
High Density Mapping in Brugada Syndrome
Artificial Intelligence for the Prioritization of Genetic Background in Brugada Syndrome
Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies
Feasibility of Improving Risk Stratification in Brugada Syndrome
Physical Activity in Children With Inherited Cardiac Diseases
UZ Brussel HRMC Registry of Brugada Syndrome
Defining the Electrocardiographic Effect of Propofol on the Ajmaline Provocation Drug Challenge: A Prospective Trial